Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NEW JCM GROUP
300157
5
Shenzhen S-king Intelligent Equipment
688328
US Stock MarketDetailed Quotes
ZURA Zura Bio
- 1.370
- -0.070-4.86%
Close Apr 25 16:00 ET
- 1.370
- -0.001-0.04%
Pre 08:00 ET
93.67MMarket Cap-2.28P/E (TTM)
1.450High1.320Low163.09KVolume1.410Open1.440Pre Close226.86KTurnover0.35%Turnover RatioLossP/E (Static)68.37MShares6.35052wk High0.64P/B63.87MFloat Cap0.97052wk Low--Dividend TTM46.62MShs Float37.550Historical High--Div YieldTTM9.03%Amplitude0.970Historical Low1.391Avg Price1Lot Size
About Zura Bio Company
Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
Company Profile
SymbolZURA
Company NameZura Bio
Listing DateMar 21, 2023
Founded2022
CEOMr. Robert Lisicki
MarketNASDAQ
Employees30
Fiscal Year Ends12-31
Address1489 West Warm Springs Road,Suite 110
CityHenderson
ProvinceNevada
CountryUnited States of America
Zip Code89014
Phone1-702-757-6133
Websitehttp://zurabio.com
Company Executives
- Name
- Position
- Salary
- Robert Lisicki
- Chief Executive Officer and Director
- 6.66M
- Kimberly Ann Davis
- Chief Operating Officer, Secretary and Chief Legal Officer
- 1.80M
- Verender S. Badial
- Chief Financial Officer and Chief Accounting Officer
- --
- Dr. Kiran Nistala, M.B.B.S.,PhD
- Chief Medical Officer and Head, Development
- 2.53M
- Dr. Gary Whale, PhD
- Chief Technology Officer
- --
- Amit D. Munshi
- Chairman of the Board
- 338.21K
- Dr. Someit Sidhu, M.D.
- Director
- 1.01M
- Jennifer Ann Jarrett
- Independent Director
- 307.21K
- Steven J. Schoch
- Independent Director
- 315.21K
- Parvinder Thiara
- Independent Director
- 473.09K
- Arnout Ploos van Ael
- Independent Director
- 464.33K
- Dr. Sandeep C. Kulkarni, M.D.
- Independent Director
- 317.21K
- Dr. Neil Graham, M.B.B.S.,M.D.,M.P.H.
- Independent Director
- 305.21K
- Dr. Daniel Becker, M.D.,PhD
- Independent Director
- --
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now